Dipeptidyl peptidase-4 inhibitor for steroid-induced diabetes.

The addition of the dipeptidyl peptidase-4 (DDP-4) inhibitor has been reported to achieve greater improvements in glucose metabolism with fewer adverse events compared to increasing the metformin dose in type 2 diabetic patients. We present a patient with steroid-induced diabetes whose blood glucose levels were ameliorated by the use of the DPP-4 inhibitor, showing that the DPP-4 inhibitors may be an effective and safe oral anti-diabetic drug for steroid-induced diabetes.

• Publication year

  2010

• Venue

  World Journal of Diabetes

• Publication date

  2010-07-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.4239/wjd.v1.i3.99PMID 21537433PMCID PMC3083887
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of vildagliptin as add-on therapy to a low-dose metformin.

  2010cited by this paper
• Combination of the Dipeptidyl Peptidase IV Inhibitor LAF237 [(S)-1-[(3-Hydroxy-1-adamantyl)ammo]acetyl-2-cyanopyrrolidine] with the Angiotensin II Type 1 Receptor Antagonist Valsartan [N-(1-Oxopentyl)-N-[[2′-(1H-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl]methyl]-l-valine] Enhances Pancreatic Islet Morpholo

  2008cited by this paper
• Efficacy and safety of the dipeptidyl peptidase‐4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double‐blind, non‐inferiority trial

  2007cited by this paper
• The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes.

  2006cited by this paper
• Steroid‐Induced Diabetes Mellitus and Related Risk Factors in Patients with Neurologic Diseases

  2004cited by this paper
• Effective use of thiazolidinediones for the treatment of glucocorticoid-induced diabetes.

  2002cited by this paper
• Treatment for steroid‐induced diabetes with α‐glucosidase inhibitor, voglibose

  1998cited by this paper

• Association of Dipeptidyl Peptidase-4 Inhibitor Use with COVID-19 Mortality in Diabetic Patients: A Nationwide Cohort Study in Korea

  2025cites this paper
• Is It Time for a New Algorithm for the Pharmacotherapy of Steroid-Induced Diabetes?

  2024cites this paper
• Medical treatment of Cushing’s disease with concurrent diabetes mellitus

  2023cites this paper
• Management of Glucocorticoid-Induced Hyperglycemia

  2022cites this paper
• Management of Glucocorticoid-Induced Hyperglycemia Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

  2022cites this paper
• Short-term glucocorticoid-related side effects and adverse reactions: a narrative review and practical approach.

  2022cites this paper
• The effect of liraglutide on insulin allergy in a patient with glucocorticoid-induced diabetes and multiple sclerosis

  2021cites this paper
• GLUCOSE EXCHANGE DISORDERS IN PATIENTS TAKING GLUCOCORTICOSTEROIDS: FEATURES OF CLINICAL MANIFESTATIONS AND CORRECTION

  2019cites this paper
• Incidence of hyperglycemia in patients with corticosteroid therapy

  2018cites this paper
• Diabetes Mellitus Secondary to Cushing’s Disease

  2018cites this paper
• The Efficacious and Safe Treatment for Steroid-Induced Hyperglycemia

  2018cites this paper
• Steroid-Induced Hyperglycemia Successfully Treated With Once-Weekly Dulaglutide in an Old Patient With Type 2 Diabetes

  2018cites this paper
• Glucocorticoid-Induced Diabetes Mellitus: An Important but Overlooked Problem

  2017cites this paper
• Management of Steroid-induced Hyperglycemia

  2016cites this paper
• [Management and Treatment of Glucocorticoid-Induced Hyperglycemia].

  2016cites this paper
• Effects of 6-Month Sitagliptin Treatment on Metabolic Parameters in Diabetic Patients Taking Oral Glucocorticoids: A Retrospective Cohort Study

  2015cites this paper
• Risk factors for the development of glucocorticoid-induced diabetes mellitus.

  2015cites this paper
• Incretin based therapy in the management of steroid induced diabetes mellitus.

  2015cites this paper
• Genetic basis of dyslipidemia in disease precipitation of coronary artery disease (CAD) associated type 2 diabetes mellitus (T2DM)

  2015cites this paper
• Effects of sitagliptin and sitagliptin in combination with omega-3 on newly diagnosed type 2 diabetic Iraqi patients

  2014cites this paper
• Alogliptin improves steroid-induced hyperglycemia in treatment-naïve Japanese patients with chronic kidney disease by decrease of plasma glucagon levels

  2014cites this paper
• Formulation and characterisation of self-microemulsifying drug delivery system of pioglitazone

  2013cites this paper
• Early diagnosis and treatment of steroid-induced diabetes mellitus in patients with rheumatoid arthritis and other connective tissue diseases

  2013cites this paper
• Sitagliptin counteracts seasonal fluctuation of glycemic control.

  2012cites this paper
• Types of Diabetes that the Dipeptidyl Peptidase-4 Inhibitor May Act Effectively and Safely

  2011cites this paper
• Relationship between concurrent use of antidepressants and anti-diabetics according to different numbers of antidepressants and different regimens of diabetes treatment

  2011cites this paper